The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China

Volume: 54, Issue: 8, Pages: 1094 - 1100
Published: Aug 1, 2022
Abstract
Whether the anti-gp210 antibody can be used as a biomarker in patients with primary biliary cholangitis (PBC) remains controversial.We aimed to investigate the association between anti-gp210 antibodies and prognosis in ursodeoxycholic acid (UDCA)-treated PBC patients.We conducted a retrospective cohort study of 180 UDCA-treated PBC patients to assess the prognostic value of anti-gp210 antibodies using the Kaplan-Meier method and Cox proportional...
Paper Details
Title
The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China
Published Date
Aug 1, 2022
Volume
54
Issue
8
Pages
1094 - 1100
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.